Reported 1,140,057 shares, down 213,826 (15.8%) from the prior quarter.
Reported value 18.8%; share count -15.8% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 62673000 |
| 2022-03-31 | 65956000 |
| 2022-06-30 | 72309000 |
| 2022-09-30 | 87108000 |
| 2022-12-31 | 118856000 |
| 2023-03-31 | 91736000 |
| 2023-06-30 | 85831000 |
| 2023-09-30 | 89552000 |
| 2023-12-31 | 82293000 |
| 2024-03-31 | 89369000 |
| 2024-06-30 | 114145000 |
| 2024-09-30 | 100872000 |
| 2024-12-31 | 83459000 |
| 2025-03-31 | 93475000 |
| 2025-06-30 | 74104000 |
| 2025-09-30 | 92535000 |
| 2025-12-31 | 84439000 |
| 2026-03-31 | 90086000 |
| 2026-06-30 | 105969000 |
| 2026-09-30 | 125863000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 1,140,057 | -213,826 (-15.8%) | 1.07% | $125,863,000 | 2026-11-10 | |
| Q2 2026 | Reduced | 1,353,883 | -39,992 (-2.9%) | 0.83% | $105,969,000 | 2026-08-12 | |
| Q1 2026 | Added | 1,393,875 | +139,227 (11.1%) | 0.79% | $90,086,000 | 2026-05-13 | |
| Q4 2025 | Reduced | 1,254,648 | -7,069 (-0.6%) | 0.73% | $84,439,000 | 2026-02-11 | |
| Q3 2025 | Reduced | 1,261,717 | -162,799 (-11.4%) | 0.82% | $92,535,000 | 2025-11-12 | |
| Q2 2025 | Reduced | 1,424,516 | -40,375 (-2.8%) | 0.66% | $74,104,000 | 2025-08-11 | |
| Q1 2025 | Reduced | 1,464,891 | -280,750 (-16.1%) | 0.87% | $93,475,000 | 2025-05-05 | |
| Q4 2024 | Reduced | 1,745,641 | -16,620 (-0.9%) | 0.71% | $83,459,000 | 2025-02-05 | |
| Q3 2024 | Reduced | 1,762,261 | -417,744 (-19.2%) | 0.86% | $100,872,000 | 2024-11-07 | |
| Q2 2024 | Reduced | 2,180,005 | -16,872 (-0.8%) | 1.04% | $114,145,000 | 2024-08-12 | |
| Q1 2024 | Reduced | 2,196,877 | -29,661 (-1.3%) | 0.79% | $89,369,000 | 2024-05-08 | |
| Q4 2023 | Reduced | 2,226,538 | -117,767 (-5.0%) | 0.77% | $82,293,000 | 2024-02-09 | |
| Q3 2023 | Reduced | 2,344,305 | -35,284 (-1.5%) | 0.9% | $89,552,000 | 2023-11-09 | |
| Q2 2023 | Reduced | 2,379,589 | -22,526 (-0.9%) | 0.81% | $85,831,000 | 2023-08-09 | |
| Q1 2023 | Added | 2,402,115 | +313,259 (15.0%) | 0.89% | $91,736,000 | 2023-05-09 | |
| Q4 2022 | Reduced | 2,088,856 | -114,186 (-5.2%) | 1.21% | $118,856,000 | 2023-02-10 | |
| Q3 2022 | Added | 2,203,042 | +559,654 (34.1%) | 0.96% | $87,108,000 | 2022-11-09 | |
| Q2 2022 | Reduced | 1,643,388 | -10,471 (-0.6%) | 0.78% | $72,309,000 | 2022-08-09 | |
| Q1 2022 | Added | 1,653,859 | +95,215 (6.1%) | 0.59% | $65,956,000 | 2022-05-09 | |
| Q4 2021 | Added | 1,558,644 | +59,875 (4.0%) | 0.52% | $62,673,000 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
826 managers reported HALOZYME THERAPEUTICS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 13,668,566 | +397,471 | 0.02% | $1,509,009,584 | 9 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 5,106,451 | -244,861 | 0.01% | $563,752,190 | 3 qtrs |
| STATE STREET CORPORATION | Reduced | 5,063,578 | -115,856 | 0.02% | $559,019,011 | 54 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 4,986,956 | -312,052 | 0.02% | $550,559,942 | 3 qtrs |
| Invesco Ltd | Added | 3,534,220 | +356,223 | 0.03% | $390,177,887 | 46 qtrs |
| TWO SIGMA INVESTMENTS LP | Added | 3,519,157 | +1,865,872 | 0.27% | $388,514,933 | 11 qtrs |
| D E Shaw & Co Inc | Added | 3,373,506 | +1,367,027 | 0.18% | $372,435,062 | 41 qtrs |
| MORGAN STANLEY | Added | 2,850,713 | +18,119 | 0.02% | $314,718,948 | 54 qtrs |
| Boston Partners | Reduced | 2,763,837 | -9,731 | 0.27% | $305,123,609 | 13 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 2,414,434 | -105,517 | 0.01% | $266,611,110 | 54 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 10, 2026
- Filing type
- 13F-HR
- Position type
- COMMON
Voting authority reported
- Sole
- 1,072,018
- Shared
- 67,611
- None
- 427
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.